Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis

Dhiraj Dhoot, Gaurav Kumar Jain, Mukesh Manjhi, Prashant Kesharwani, Namrata Mahadkar, Hanmant Barkate

Article Type

Original Research

Published

This study compares the rate and extent of serum and sebum concentration of super-bioavailable itraconazole and conventional itraconazole at different dosing to determine their efficacy and safety in patients with dermatophytosis.

Read more

Addressing COVID-19 vaccine hesitancy

George Kassianos, Joan Puig-Barberà, Hannah Dinse, Martin Teufel, Özlem Türeci, Shanti Pather

Article Type

Review

Published

This article seeks to summarize the currently available information to address the most common concerns regarding COVID-19 vaccination.

Read more

Thalidomide and discoid lupus erythematosus: case series and review of literature

Giovanna Malara, Chiara Verduci, Maria Altomonte, Maria Cuzzola, Caterina Trifirò, Cristina Politi, Giovanni Tripepi

Article Type

Case Series

Published

This article reports four cases of discoid lupus erythematosus treated previously with the most common immunomodulatory agents with no results and finally successfully treated with thalidomide.

Read more

Paediatrics: how to manage pediculosis capitis

Alexander KC Leung, Joseph M Lam, Kin Fon Leong, Benjamin Barankin, Kam Lun Hon

Article Type

Review

Published

Pediculosis capitis is a common human parasitic infestation in childhood. This article aims to provide a narrative updated review on the management of pediculosis capitis.

Read more

Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19

Sergey V Efimov, Natallia V Matsiyeuskaya, Olga V Boytsova, Luydmila Yu Akhieva, Elena V Kuntsevich, Anastasia A Troshina, Elena I Kvasova, Anton A Tikhonov, Nadezhda F Khomyakova, Francisco Harrison, Jean-François Rossi, Timothy C Hardman

Article Type

Original Research

Published

This study evaluated the safety and efficacy of azoximer bromide when used in combination with standard of care treatment in patients hospitalized with COVID-19.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.